Log In
Print this Print this

Amitiza, lubiprostone (SPI-0211)

  Manage Alerts
Collapse Summary General Information
Company Sucampo Pharmaceuticals Inc.
DescriptionFunctional fatty acid chloride channel activator
Molecular Target Chloride channel 2 (CLCN2) (ClC-2) ; Potassium channel KCa1.1 (KCNMA1) (SLO)
Mechanism of ActionCl channel activator
Therapeutic ModalityMacromolecule: Fatty acid/lipid

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today